Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 2
1970 1
1971 1
1973 1
1974 4
1975 4
1976 8
1977 1
1978 1
1979 5
1980 4
1981 3
1982 4
1983 6
1984 9
1985 4
1986 8
1987 5
1988 13
1989 9
1990 12
1991 15
1992 19
1993 20
1994 15
1995 14
1996 20
1997 25
1998 24
1999 22
2000 18
2001 30
2002 39
2003 34
2004 44
2005 53
2006 50
2007 51
2008 51
2009 64
2010 52
2011 58
2012 67
2013 93
2014 83
2015 72
2016 94
2017 103
2018 100
2019 114
2020 116
2021 134
2022 107
2023 81
2024 24

Text availability

Article attribute

Article type

Publication date

Search Results

1,793 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Gastrointestinal infarctions"
Page 1
Traditional Chinese Medicine Compound (Tongxinluo) and Clinical Outcomes of Patients With Acute Myocardial Infarction: The CTS-AMI Randomized Clinical Trial.
Yang Y, Li X, Chen G, Xian Y, Zhang H, Wu Y, Yang Y, Wu J, Wang C, He S, Wang Z, Wang Y, Wang Z, Liu H, Wang X, Zhang M, Zhang J, Li J, An T, Guan H, Li L, Shang M, Yao C, Han Y, Zhang B, Gao R, Peterson ED; CTS-AMI Investigators. Yang Y, et al. JAMA. 2023 Oct 24;330(16):1534-1545. doi: 10.1001/jama.2023.19524. JAMA. 2023. PMID: 37874574 Clinical Trial.
IMPORTANCE: Tongxinluo, a traditional Chinese medicine compound, has shown promise in in vitro, animal, and small human studies for myocardial infarction, but has not been rigorously evaluated in large randomized clinical trials. OBJECTIVE: To investigate whether Tongxinlu …
IMPORTANCE: Tongxinluo, a traditional Chinese medicine compound, has shown promise in in vitro, animal, and small human studies for myocardi …
Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement.
US Preventive Services Task Force; Davidson KW, Barry MJ, Mangione CM, Cabana M, Chelmow D, Coker TR, Davis EM, Donahue KE, Jaén CR, Krist AH, Kubik M, Li L, Ogedegbe G, Pbert L, Ruiz JM, Stevermer J, Tseng CW, Wong JB. US Preventive Services Task Force, et al. JAMA. 2022 Apr 26;327(16):1577-1584. doi: 10.1001/jama.2022.4983. JAMA. 2022. PMID: 35471505
Each year, an estimated 605 000 people in the US have a first myocardial infarction and an estimated 610 000 experience a first stroke. OBJECTIVE: To update its 2016 recommendation, the US Preventive Services Task Force (USPSTF) commissioned a systematic review on the effe …
Each year, an estimated 605 000 people in the US have a first myocardial infarction and an estimated 610 000 experience a first strok …
Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial.
Gaziano JM, Brotons C, Coppolecchia R, Cricelli C, Darius H, Gorelick PB, Howard G, Pearson TA, Rothwell PM, Ruilope LM, Tendera M, Tognoni G; ARRIVE Executive Committee. Gaziano JM, et al. Lancet. 2018 Sep 22;392(10152):1036-1046. doi: 10.1016/S0140-6736(18)31924-X. Epub 2018 Aug 26. Lancet. 2018. PMID: 30158069 Free PMC article. Clinical Trial.
The primary efficacy endpoint was a composite outcome of time to first occurrence of cardiovascular death, myocardial infarction, unstable angina, stroke, or transient ischaemic attack. ...In the intention-to-treat analysis, the primary endpoint occurred in 269 (4.29%) pat …
The primary efficacy endpoint was a composite outcome of time to first occurrence of cardiovascular death, myocardial infarction, uns …
Atlas of gut microbe-derived products from aromatic amino acids and risk of cardiovascular morbidity and mortality.
Nemet I, Li XS, Haghikia A, Li L, Wilcox J, Romano KA, Buffa JA, Witkowski M, Demuth I, König M, Steinhagen-Thiessen E, Bäckhed F, Fischbach MA, Tang WHW, Landmesser U, Hazen SL. Nemet I, et al. Eur Heart J. 2023 Aug 22;44(32):3085-3096. doi: 10.1093/eurheartj/ehad333. Eur Heart J. 2023. PMID: 37342006
Multiple aromatic amino acid-derived metabolites that originate, at least in part, from gut bacteria are associated with incident (3-year) major adverse cardiovascular event (MACE) risks (myocardial infarction, stroke, or death) and all-cause mortality independent of tradi …
Multiple aromatic amino acid-derived metabolites that originate, at least in part, from gut bacteria are associated with incident (3-year) m …
Gut microbiota combined with metabolites reveals unique features of acute myocardial infarction patients different from stable coronary artery disease.
Dong C, Yang Y, Wang Y, Hu X, Wang Q, Gao F, Sun S, Liu Q, Li L, Liu J, Tang Y, Zhang S, Wu C, Zhu H. Dong C, et al. J Adv Res. 2023 Apr;46:101-112. doi: 10.1016/j.jare.2022.06.008. Epub 2022 Jun 21. J Adv Res. 2023. PMID: 35750287 Free PMC article.
INTRODUCTION: Acute myocardial infarction (AMI) accounts for the majority of deaths caused by coronary artery disease (CAD). ...
INTRODUCTION: Acute myocardial infarction (AMI) accounts for the majority of deaths caused by coronary artery disease (CAD). ...
Aspirin for Primary Prevention.
Richman IB, Owens DK. Richman IB, et al. Med Clin North Am. 2017 Jul;101(4):713-724. doi: 10.1016/j.mcna.2017.03.004. Med Clin North Am. 2017. PMID: 28577622 Review.
Aspirin reduces the risk of nonfatal myocardial infarction and stroke, and the risk of colorectal cancer. Aspirin increases the risk of gastrointestinal and intracranial bleeding. ...
Aspirin reduces the risk of nonfatal myocardial infarction and stroke, and the risk of colorectal cancer. Aspirin increases the risk …
The MOVEMENT Trial.
Holm M, Tornvall P, Henareh L, Jensen U, Golster N, Alström P, Santos-Pardo I, Witt N, Fedchenko N, Venetsanos D, Beck O, van der Linden J. Holm M, et al. J Am Heart Assoc. 2019 Jan 22;8(2):e010152. doi: 10.1161/JAHA.118.010152. J Am Heart Assoc. 2019. PMID: 30636504 Free PMC article. Clinical Trial.
Background Morphine administration is a strong predictor of delayed onset of action of orally administered ticagrelor in patients with ST-segment-elevation myocardial infarction, likely because of impaired gastrointestinal motility. The aim of this study was to eval …
Background Morphine administration is a strong predictor of delayed onset of action of orally administered ticagrelor in patients with ST-se …
Management of acute mesenteric ischaemia: Results of a worldwide survey.
Hess B, Cahenzli M, Forbes A, Burgos R, Coccolini F, Corcos O, Holst M, Irtun Ø, Klek S, Pironi L, Rasmussen HH, Serlie MJ, Thibault R, Gabe S, Reintam Blaser A; ESPEN Special Interest Group on Acute Intestinal Failure ESPEN (European Society for Clinical Nutrition and Metabolism). Hess B, et al. Clin Nutr ESPEN. 2023 Apr;54:194-205. doi: 10.1016/j.clnesp.2022.12.022. Epub 2023 Jan 5. Clin Nutr ESPEN. 2023. PMID: 36963863 Free article.
Emergency revascularisation is often considered for patients with AMI but rarely in cases of transmural ischaemia (intestinal infarction). Responses from team hospitals with a dedicated special unit (14 team forms) indicated more aggressive revascularisation. ...Medical hi …
Emergency revascularisation is often considered for patients with AMI but rarely in cases of transmural ischaemia (intestinal infarction …
Ticagrelor vs Clopidogrel in Acute Myocardial Infarction Patients With a History of Ischemic Stroke.
Huang HY, Wang CC, Katz AJ, Lin SY, Lin FJ, Wu CH. Huang HY, et al. Mayo Clin Proc. 2023 Nov;98(11):1602-1612. doi: 10.1016/j.mayocp.2023.07.005. Mayo Clin Proc. 2023. PMID: 37923519
OBJECTIVE: To investigate whether use of ticagrelor compared to clopidogrel is associated with different risks for thrombotic events or major bleeding among acute myocardial infarction (AMI) patients with a prior history of acute ischemic stroke. ...The primary safety outc …
OBJECTIVE: To investigate whether use of ticagrelor compared to clopidogrel is associated with different risks for thrombotic events or majo …
Prognostic value of gut microbiota-derived metabolites in patients with ST-segment elevation myocardial infarction.
Zhao S, Tian Y, Wang S, Yang F, Xu J, Qin Z, Liu X, Cao M, Zhao P, Zhang G, Wang Z, Zhang Y, Wang Y, Lin K, Fang S, Wang Z, Han T, Tian M, Yin H, Tian J, Yu B. Zhao S, et al. Am J Clin Nutr. 2023 Mar;117(3):499-508. doi: 10.1016/j.ajcnut.2022.12.013. Epub 2022 Dec 28. Am J Clin Nutr. 2023. PMID: 36811471 Free article.
BACKGROUND: Studies about the prognostic role of gut microbiota-derived metabolites including phenylacetyl glutamine (PAGln), indoxyl sulfate (IS), lithocholic acid (LCA), deoxycholic acid (DCA), trimethylamine (TMA), trimethylamine N-oxide (TMAO), and its precursor trimethyllysi …
BACKGROUND: Studies about the prognostic role of gut microbiota-derived metabolites including phenylacetyl glutamine (PAGln), indoxyl sulfat …
1,793 results